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Photodynamic antimicrobial chemotherapy based on photosensitizers activated by illumination is limited by poor penetration of
visiblelightthroughskinandtissues.Inordertoovercomethisproblem,RoseBengalwasexcitedinthedarkby28kHzultrasound
and was applied for inactivation of bacteria. It is demonstrated, for the �rst time, that the sonodynamic technique is eﬀective for
eradicationofGram-positiveStaphylococcusaureusandGram-negativeEscherichiacoli.enetsonodynamiceﬀectwascalculated
asa3-4log10 reductioninbacteriaconcentration,dependingonthecellandtheRoseBengalconcentrationandthetreatmenttime.
Sonodynamic treatment may become a novel and eﬀective form of antimicrobial therapy and can be used for low-temperature
sterilization of medical instruments and surgical accessories.
1. Introduction
e �eld of photodynamic antimicrobial chemotherapy
(PACT) is currently under intense investigation and is show-
ing promising prospects as an alternative to antibiotic treat-
ment in view of increasing widespread bacterial resistance to
antibiotics[1,2].AclassicalschemeofPACTincludesexcita-
tion of low toxic components—photosensitizers (PS) by visi-
blelight,whenlight-activatedPSmoleculestransferenergyto
molecularoxygen,whichresultsintheproductionofreactive
oxygen species that in turn cause irreversible damage to
cellular components [1, 3–7]. e list of PS includes a wide
spectrum of compounds, such as porphyrins, phenothiazini-
ums, phthalocyanines, hypocrellin derivatives, squaraine
derivatives (squaraine dyes, squaric acid derivatives), boron
dipyrromethenederivatives,andchlorinederivatives[4,6,8].
PACT has been extensively studied as a strategy against both
Gram-positive and Gram-negative bacteria [9, 10], including
antibiotic-resistantspecies[11]andappearstooccupyaniche
for control of oral [12] and other localized infections [11]. It
should be noted that no development of bacterial resistance
toPShasbeenreportedtodatefromthenumerousstudieson
the eﬀect of PACT against diﬀerent microorganisms [13, 14].
e major disadvantage of PACT is the limited tissue
penetration of external light. Despite advances in the devel-
opment of light source devices for phototherapy [15, 16] and
the clinical use of PACT in dermatology [5, 17], treatment of
internal body tissues remains limited to invasive procedures.
O n l yaf e wa t t e m p t st od e v e l o pa l t e r n a t i v em e a n so fP S
activation have been reported to date. We [18–20] and
others [21] developed an approach in which the external
light source was replaced by chemiluminescent light emitted
during the course of a chemical reaction. We used the
chemiluminescent oxidation of luminol, in which the release
of light energy was achieved without electrical or thermal
input in the course of in situ conversion of molecular oxygen
tosuperoxideions.istechnology,calledchemiluminescent
photodynamic antimicrobial therapy (CPAT), was shown to
be eﬀective against Gram-negative E. coli and Gram-positive
S.aureus(bothmethicillin-sensitiveandmethicillin-resistant
strains) [19, 20]. Our data showed that CPAT was almost as
eﬀective as PACT. CPAT can therefore compete with PACT2 BioMed Research International
in eradicating a wide range of Gram-positive and Gram-
negativebacteria,includingantibiotic-resistantstrains.CPAT
may thus become a novel antimicrobial therapeutic strategy
and might be applicable for internal infections that are
diﬃcult to target and treat using traditional PACT.
Another interesting technique of PS activation that
does not use an external light source is sonodynamic
excitation by ultrasound. Sonodynamic therapy (SDT) based
on ultrasound-induced cytotoxicity of compounds called
sonosensitizers has already been studied for cancer cell inhi-
bition. e sonosensitizers include widely used anti-cancer
drugs such as bleomycin, adriamycin, amphotericin B, mit-
omycin C, daunomycin, diaziquone, and 5-�uorouracil [22],
as well as several PS, such as hematoporphyrin, photofrin,
mesoporphyrin, protoporphyrin, pheophorbide-a, ATX-70
(7,12-bis(1-decyloxyethyl)-Ga(III)-3,8,13,17-tetramethyl-
porphyrin-2,18-dipropionyl diaspartic acid), Rose Bengal
(RB), zinc(II)-phthalocyanine, and some others [22–29].
Generally speaking, the term SDT can be used for all
nonthermally related therapeutic ultrasound applications,
ranging from induction of apoptosis when combined with
chemotherapy to ultrasound therapy. However, most authors
usethetermSDTforultrasonicactivationofdrugsforcancer
therapy [30]. e exact mechanism of SDT has not been
entirely elucidated. Furthermore, it is assumed that there is
no universal mechanism for synergism between ultrasound
and drugs, such that diﬀerent classes of sonosensitizers can
be activated in the dark by diﬀerent mechanisms [22, 31].
e biological eﬀects of SDT are associated with one of three
diﬀerent mechanisms: heat, mechanical eﬀects, and acoustic
cavitation [32]. ese eﬀects depend on the intensity and
frequency of the ultrasound: high intensity sonication leads
to heat production, whereas low frequency treatment causes
cavitation. Exposure of biological tissues to ultrasound can
result in structural and/or functional changes of cells [32].
Mišík and Riesz believe that biological eﬀects of SDT may be
expressed due to one or two combinations of several factors:
thermal eﬀects (absorption and dissipation of ultrasound
energy), cell membrane permeability changes and/or cell
membrane rupture, and free radical eﬀects [31]. e data
obtained in their study show that photosensitizers (e.g.,
porphyrins) can be sonosensitized according to the follow-
ing scheme: a drug undergoes pyrolysis inside collapsing
cavitation bubbles or in the heated gas-liquid interface,
formingfreeradicalintermediateswhichreactwithdissolved
oxygen to form peroxyl radicals, and the latter attack cellular
sites due to their ability to diﬀuse to signi�cant distances
[31].
Other authors explain the sonodynamic eﬀect of por-
phyrins by electronic excitation of the molecules by sonolu-
minescence, that is, light �ashes produced during the course
of acoustic cavitation in liquids generated with ultrasound
energy without application of external illumination. Sonolu-
minescenceinitiatesphotochemicalprocessesresultinginthe
formation of cytotoxic singlet oxygen [22, 29, 33].
A large number of serious studies are dedicated to
SDT of cancer cells, and to the best of our knowledge,
this technique has never been applied for eradication of
bacteria. In 2009, Ma et al. [34] hypothesized that ultrasound
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F 1: e scheme for the SACT experiments. 2.5cm diameter
�at-bottomedvialswithbacterialsuspensionsinRBorMBsolutions
were treated with 28kHz ultrasound at an intensity of 0.84Wcm
−2
in an ultrasonic bath in the dark.
may be exploited for treatment of infectious bacterial and
viral diseases and proposed a new concept of sonodynamic
antimicrobial chemotherapy (SACT) as a promising novel
antimicrobialstrategy.However,thishypothesishasnotbeen
proven experimentally.
In the present work it is demonstrated, for the �rst time,
that SACT can indeed be realized. We show that Gram-
positiveS.aureusandGram-negativeE.colicanbeeradicated
by RB activated with ultrasound in the dark.
2. Materials and Methods
2.1. Bacterial Growth. Cultures of Staphylococcus aureus
(ATCC 25923) and Escherichia coli (ATCC 10798) were
grown on brain-heart agar (BHA, Acumedia, USA) for 24h,
thenweretransferredintobrain-heartbroth(BH,Acumedia,
USA) and were grown at 37
∘Ca n da ta1 7 0 r p ms p e e do f
shaking up to concentration of 10
9 CFUmL
−1, centrifuged
for5minat10,000rpmanddilutedbysterile0.05MPBS,pH
7.5, to concentrations of 106–109CFUmL
−1.
2.2. Solutions of PS. Stock aqueous solutions of RB and
Methylene Blue (MB) (Sigma-Aldrich, USA) were prepared
in 0.016mM and 0.013mM concentrations, respectively,
in PBS and �ltered by sterile �ltration through 0.22𝜇𝜇m
membranes (Pall Corporation, USA). Visible spectra of the
PSwereregisteredusingUV-VisibleSpectrophotometerCary
50 Bio (Varian, Australia).
2.3. Testing of SACT. PS solutions were added to 10mL
portions of diluted S. aureus or E. coli in �at-bottom 2.5cm
diameter vials (solution height in the vials was 2cm) and
incubated for 15min in the dark. Vials were held in a plastic
holder tight to the bottom of an ultrasonic bath WUG-
AO2H (Wise Clean Company, Korea) at 10
∘C and sonicated
for 1-2h at an ultrasound frequency of 28kHz and an
intensity of 0.84Wcm
−2 (Figure 1). Strict conditions were
maintained in order to prevent any external illumination
duringtheexperiments.100𝜇𝜇Lbacteriasampleswerediluted
in several decimal dilutions and were spread over BHA
plates with a Drigalsky spreader. e plates were incubatedBioMed Research International 3
T 1: SACT eﬀect of RB on E. coli cells at various initial concentrations.
log10𝐶𝐶0
RB concentration, 𝜇𝜇M
0 5 10 15
+
∗ − + − + − + −
6 5.8 6.1 3.2 5.6 2.0 5.5 1.3 5.5
7 7.0 6.9 5.6 6.8 4.5 6.3 3.7 6.3
9 7.1 9.0 6.8 9.0 6.0 8.2 5.0 8.1
∗
Plus (+) designates SACT treated samples and minus (−) designates controls. Treatment time was 1h. 𝐶𝐶0: initial cell concentration, CFUmL
−1.
at 37
∘C overnight and CFU (colony-forming units) were
countedtakingdilutionsintoaccount.Incontrolexperiments
bacterial cultures were tested in the absence of PS without
sonication, in the absence of PS under sonication and in the
presence of PS without sonication.
2.4. Testing of PACT. PACT experiments were carried out by
illumination of bacteria cultured as described above in liquid
BH medium, mixed with solutions of MB in glass test-tubes,
incubated for 15min in the dark and illuminated for 30min
at room temperature under temperature control by an 18W
white luminescent lamp placed at a distance of 15cm from
the tubes. Light intensity was 10.6klux and a �uence rate
was 1.6mWcm
−2. Light intensity was measured by a LX-102
Light-meter (Lutron, Taiwan). Samples were not sonicated in
the PACT experiments.
2.5. Statistical Methods.  er e s u l t so b t a i n e df r o ma tl e a s t
3 independent experiments ful�lled with duplicates were
statistically analyzed by Anova single factor or by Anova
two-factor analyses. e diﬀerence between the results was
considered signi�cant if the 𝑃𝑃 value was less than 0.05.
3. Resultsand Discussion
Two types of cells were chosen for primary evaluation of
the suitability of SDT for eradication of bacteria—E. coli
for representing Gram-negative bacteria and S. aureus as a
member of the Gram-positive group. Two compounds, RB
and MB, were selected as potential sonosensitizers. ese
compounds are well known for their photodynamic activity
against the chosen bacteria [19, 35–39] ,a n dw h a ti sm o r e ,
sonodynamic anticancer activity of RB has been reported
in several works [26, 40]. e sonodynamic activity of MB
has not been studied, to the best of our knowledge, but
several authors believe that photosensitizers are generally
good candidates for exhibiting sonodynamic properties [22,
28]. RB and MB have good solubility in water, and this fact
enabled building an experimental scheme based on their free
forms in aqueous solutions.
e experiments for testing sonodynamic antibacterial
properties of RB and MB were held in the dark in an
ultrasonic bath with cold water (Figure 1). Pieces of ice were
periodically added to the bath in order to compensate for
heating of the water during the sonication procedure. All
operations were performed in the dark in order to exclude
any possibility of photodynamic excitation of the examined
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F 2: SACT eﬀect of RB on E. coli. Cells at initial concentration
of 10
6 CFUmL
−1 were incubated with 0–15𝜇𝜇M RB in an ultrasonic
bath for 1h in the dark. Controls: not sonicated bacterial cultures
with or without PS. Aer the treatment, bacterial samples were
serially diluted in 10-fold dilutions and evenly spread over BHA
plates with a Drigalsky spreader. Plates were incubated at 37
∘C
overnight and CFU were counted.
compounds. e following control experiments were carried
out in all series in the dark: incubation of bacteria without
sonication in the absence of RB and MB, incubation of
bacteria without sonication in the presence of RB or MB,
and sonication of bacteria in the absence of RB and MB.
Various concentrations of the bacterial cultures were added
to buﬀered aqueous solutions of RB or MB in �at vials and
placed on the bottom of the ultrasound bath for sonication
(Figure 1). e control vials, which were not sonicated, were
incubated under similar conditions outside the bath in the
dark.
e results of the SACT experiments demonstrating a
sonodynamic eﬀect of RB on E. coli are presented in Table 1
and Figure 2, and on S. aureus in Table 2 and Figure 3.
When treated for 1h, both E. coli and S. aureus bacteria
were inhibited by RB under each tested concentration, and
an increase in RB concentration caused higher suppression.
Sonication of the cultures in the absence of RB led to
a moderate decrease in cell concentration: sonication of
cultures at a high initial bacterial concentration of E. coli
(10
9 CFUmL
−1) resulted in a ca. 2log10 decrease in the
number of CFU (Table 1), whereas sonication at a low initial
concentration (10
6 and 10
7 CFUmL
−1) had no eﬀect on
the vitality of the bacteria when compared to the untreated
control cells (𝑃𝑃 value = 0.322). Sonication of S. aureus not
treatedbyRBresultedinaca.1log10 decreaseinthebacterial
concentration for all initial bacterial cell concentrations4 BioMed Research International
T 2: SACT eﬀect of RB on S. aureus cells at various initial concentrations.
log10𝐶𝐶0
RB concentration, 𝜇𝜇M
0 1.5 3 5
+
∗ − + − + − + −
6 5.0 5.7 1.4 5.3 0.8 4.2 0.01 3.6
7 6.0 6.9 3.7 5.8 2.9 5.6 1.7 5.6
9 7.9 8.9 6.6 8.5 6.3 7.8 5.4 7.5
∗
Plus (+) designates SACT treated samples and minus (−) designates controls. Treatment time was 1h. 𝐶𝐶𝑜𝑜: initial cell concentration, CFUmL
−1.
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F 3: SACT eﬀect of RB on S. aureus. Cells at initial concen-
tration of 10
6 CFUmL
−1 were incubated with 0–5𝜇𝜇M RB in an
ultrasonic bath for 1h in the dark. Controls: not sonicated bacterial
cultures with or without PS. Aer the treatment, bacterial samples
were serially diluted in 10-fold dilutions and evenly spread over
BHAplateswith aDrigalskyspreader.Plateswereincubatedat37
∘C
overnight and CFU were counted.
(Table 2). Incubation of both bacteria in the absence of RB
withoutsonicationdidnotchangetheconcentrationofviable
cells in all cases (Tables 1 and 2). e dark eﬀect of RB,
registered in nonsonicated series, depended on the initial
cell concentration: for E. coli the maximal dark eﬀect was
ca. a 1log10 decrease (𝑃𝑃 value = 0.023) in CFU obtained for
15𝜇𝜇MRBatinitialconcentrationof10
9 CFUmL
−1 (Table 1).
is eﬀect was even smaller and actually, insigni�cant, in the
case of initial concentrations of 10
6 and 10
7 CFUmL
−1 for
all RB concentrations—a 0.1–0.6 log10 decrease in the E. coli
vitality compared to the untreated control cells (𝑃𝑃 values =
0.40–0.72). For S. aureus the maximal dark eﬀect was higher
than that for E. coli—at 5𝜇𝜇M RB for all initial concentrations
the vitality of S. aureus cells decreased by 1.5–2.5log10 in
comparisonwithuntreatedcells(𝑃𝑃values=0.0238)(Table 2).
Actually,innocasedidapplicationofeitherultrasoundorRB
separately result in high suppression of the tested bacteria.
S i m u l t a n e o u su s eo fR Ba n du l t r a s o u n di nt h ed a r ks h o w e d
quite diﬀerent results. Inhibition of the treated by 15𝜇𝜇M
RB E. coli cells was expressed by a 4–4.7 log10 decrease in
CFU compared to the untreated samples (𝑃𝑃 value = 0.041),
(Table 1), and the highest eradication rate was achieved for
an initial bacterial concentration of 10
6 CFUmL
−1 treated
by 15𝜇𝜇MRB, where the remaining E. coli concentration
dropped to only 20CFUmL
−1 (Figure 2). S. aureus was
even more sensitive to the sonodynamic treatment. e
bacteria were suppressed by 3.5–6log10 compared to the
untreated samples (𝑃𝑃 values = 0.0078–0.018) at all initial
cell concentrations (Table 2) ,a n dt r e a t m e n tb y5𝜇𝜇M RB at
an initial concentration of 10
6 CFUmL
−1 led to the most
profound eradication of S. aureus (Figure 3). Taking into
consideration separate dark and ultrasonic eﬀects, we can
concludethatthenetcontributionofsonodynamictreatment
in the dark was ca.a3l o g 10 decrease in CFU. In the cases
of both bacteria, application of SACT led to the antibacterial
cytotoxic eﬀect.
Prolonging the sonication caused a total bacterial sup-
pression even at higher initial cell concentrations. S. aureus
at an initial concentration of 10
7 CFUmL
−1 and sonicated
for 2h in the presence of 5𝜇𝜇M RB was deeply eradicated,
whereas aer a 1h treatment the number of viable cells was
50CFUmL
−1 (Figure 4).
Another PS previously shown to be very eﬀective in
photodynamic eradication of the bacteria examined in the
present study [19, 20, 38, 39], namely MB, was tested
under SACT conditions. S. aureus was studied at two initial
concentrations of 10
9 and 10
6 CFUmL
−1. MB demonstrated
a low dark eﬀect in the absence of sonication and the
concentration of S. aureus cells decreased by 1.2log10 at both
initial cell concentrations. At initial bacterial concentration
of 10
9 CFUmL
−1 sonication in the absence of MB caused
a 1.4log10 decrease in CFU, and in the presence of MB—a
1.7log10 reduction in the S. aureus concentration. e diﬀer-
ence between these data was insigni�cant (𝑃𝑃 value = 0.39).
In the case of initial cell concentration of 10
6 CFUmL
−1 the
diﬀerence was even less (Figure 5) and reached a 0.26log10
decrease in the absence of MB and a 0.3log10 decrease in the
presence of MB (𝑃𝑃 value = 0.76) e results of the control
experiments were very similar to those obtained in the RB
study (Table 2), but in contradistinction to RB, MB was
not found to exhibit any sonodynamic activity. Additional
control experiments on the photodynamic activity of MB
were performed in order to rule out possible occasional
i n a c t i v i t yo ft h eb a t c ho fM Bu s e df o rS. aureus eradication.
S. aureus illuminated by white light in the absence of MB
was practically unaﬀected, whereas the bacteria were totally
eradicated in the presence of MB (Figure 5).
Ineﬃciency of MB in the SACT experiment was quite
surp risin gf o rusa ndi tca nbeassumedtha tno tallthePSca n
be excited by ultrasound. Probably, sensitivity of PS to soni-
cation depends on the structure of the molecules, especiallyBioMed Research International 5
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F4:EﬀectoftreatmenttimeonSACTactivityofRB.S.aureus
cells at an initial concentration of 10
7 CFUmL
−1 were incubated
with 5𝜇𝜇M RB in an ultrasonic bath for 1 and 2h in the dark. Aer
the treatment, bacteria were tested by viable count.
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F 5: SACT and PACT eﬀect of MB on S. aureus. Cells at
10
6 CFUmL
−1 concentration were incubated with 30𝜇𝜇M MB in
ultrasonic bath for 1h in the dark. In PACT experiments, the cells
were illuminated for 0.5h with 1.6mWcm
−2 white light under
the same conditions but without sonication. Aer the treatment,
bacteria were tested by viable count.
on their hydrophoby and electrical charge. Undoubtedly, for
more profound investigation of this issue additional studies
should be carried out, including variation in PS, in their
concentrations and application of ultrasound in a wide range
of intensities.
We have previously examined the eﬀect of free RB on
S. aureus under photodynamic activation [38, 39] and can
now compare PACT with SACT by this compound for the
same initial bacterial concentration of 10
7 CFUmL
−1. As
was shown in [39] total eradication of cells under PACT
conditions took place at 1𝜇𝜇M RB excited by white light
MB RB
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F 6: Visible absorption spectra of 0.016mMRB and
0.013mMMB aqueous solutions. Structures of RB and MB
are shown above the spectra.e region of maximal emission
intensity of sonoluminescence in wateris designated by a blue
bracket.
at a �uence rate of 1.6mWcm
−2 applied for half an hour,
whereas the same result under the SACT regime in dark
conditions was achieved at 5𝜇𝜇M RB activated by ultrasound
applied for two hours at an intensity of 0.84Wcm
−2 and
a frequency of 28kHz. e diﬀerence between PACT and
SACT was even more drastic for MB. As demonstrated in the
present work, S. aureus was totally eradicated when activated
by light at the same MB and cell concentrations and was
almost unaﬀected when excited by ultrasound (Figure 5).
esedatademonstratethatoverall,PACTisamoreeﬀective
tool than SACT, but the eﬃciency of the latter can probably
beincreasedbyapplicationofultrasoundathigherintensities
or at diﬀerent frequencies, thus transforming this technique
into a practical and convenient tool for bacterial suppression
under dark conditions. is issue needs to be investigated
further.
e obtained data provide indirect evidence that the
mechanism of SACT is probably based on sonoluminescent
excitation of PS. Sonoluminescent light has a broadband
spectrum from 200 to 700nm, but the maximum emission
intensity of sonoluminescence in water lies between 250 and
600nm [41]. is emission range correlates well with the
absorbance spectrum of RB, but has almost no overlap with
th es pectrumo fMB(Figure6),thusaﬀordinganexplanation
for the high rate of RB activation by SACT and negligible
sonoexcitation of MB.
Figures 2 and 3 demonstrate that the Gram-positive S.
aureus responded to the sonodynamic treatment with RB
much better than the Gram-negative E. coli, where the erad-
ication rates were higher at lower applied RB concentrations
for all initial cell concentrations. e same tendency was
observed for PACT [38, 39] and was explained by diﬀerences
in the complex molecular and physico-chemical structure
of the cell membranes of the two bacterial groups [42].
e initial cell concentration played a crucial role in the
process of bacterial eradication by SACT. For all examined6 BioMed Research International
concentrations of RB the SACT eﬀect was more pronounced
for low initial bacterial concentrations and less exhibited for
concentrated bacterial suspensions. e highest eradication
ofbothbacteriawasachievedwhencellsatlowconcentration
were treated by PS at high concentration (Tables 1 and
2). Probably SACT eﬀect depends on PS dose to bacterial
concentration ratio. Analogous phenomenon of diﬀerent
eﬀect of PS on bacterial cells at various concentrations was
registered earlier in PACT experiments [39]a n di tw a s
shown that at low concentrations bacteria showed stronger
susceptibility for PACT treatment.
As in the case of cancer treatment, combating bacterial
infections in vivo can be more eﬀective and with fewer side
eﬀects when targeted to the site of infection. In addition to
known methods of targeting drugs to cells, including anti-
body, protein or peptide, liposomal, and magnetic targeting
[43–50],useofultrasoundaﬀordsadirectandexactfocusing
on the treated site. Nonactivated PS does not harm healthy
tissues. us, excitation of the PS only aer it has reached
the treatment site will prevent systemic toxic eﬀects during
delivery of the drug to the treatment site. Such targeted
treatment was carried out on cancer cells in mice by Yumita
et al. [29] and Umemura et al. [51] and resulted in cessation
of tumor growth [51] or even in destruction of tumor tissue
[29]. e same targeting scheme can undoubtedly be applied
for antibacterial treatment.
In addition to future potential therapeutic applications of
SACT, a method for cold sterilization of medical instruments
andsurgicalaccessoriescouldbeproposed.Asimpleaddition
ofsonosensitizers,forexampleofRB,totheaqueousphasein
theultrasonicbathwillsigni�cantlyimproveandincreasethe
eﬀectiveness of the sterilization process.
4. Conclusions
 ep r e s e n tw o r ks h o w sf o rt h e� r s tt i m e ,t h a ts o n o d y n a m i c
activation of RB causes eradication of E. coli and S. aureus
in the dark. e described novel SACT technique has good
prospects for becoming an eﬀective targeted tool for combat-
ing internal infections and for cold sterilization of medical
instruments.
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